Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01600430 · ClinicalTrials.gov registry record · Phase 2

Vitamin D Supplementation for Extremely Preterm Infants

A Phase 2 study of Vitamin D Deficiency and Bronchopulmonary Dysplasia, sponsored by University of Alabama at Birmingham.

Completed
Registry status
Phase 2
Development phase
100
Enrollment target
1
Study location

NCT01600430: Completed Phase 2 study of Vitamin D Deficiency and Bronchopulmonary Dysplasia, sponsored by University of Alabama at Birmingham.

NCT01600430 is a Phase 2 study of Vitamin D Deficiency and Bronchopulmonary Dysplasia that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01600430, a Phase 2 study of Vitamin D Deficiency and Bronchopulmonary Dysplasia, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The study hypothesis states that giving early enteral Vitamin D supplementation to preterm infants will decrease respiratory morbidity in extremely preterm infants.

Primary Outcome

The total number of days alive and off respiratory support. Respiratory support is defined as need of supplemental oxygen and/or positive pressure ventilation to maintain normal target oxygen saturations (88-95%).

Conditions Studied

Vitamin D Deficiency Bronchopulmonary Dysplasia Preterm Infants

Interventions

  • DIETARY_SUPPLEMENT Cholecalciferol
  • DIETARY_SUPPLEMENT Placebo

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2012-06
Est. Completion 2016-12
Phase Phase 2
University of Alabama at Birmingham

1,160 total trials

What the finished NCT01600430 record still lists

NCT01600430 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (64% lower).

The record links to 3 conditions, with Vitamin D Deficiency appearing as the primary indexed condition, and to 2 interventions - of which Cholecalciferol is the first listed.

NCT01600430 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT01600430 about?

NCT01600430 is a clinical study titled "Vitamin D Supplementation for Extremely Preterm Infants". The study hypothesis states that giving early enteral Vitamin D supplementation to preterm infants will decrease respiratory morbidity in extremely preterm infants.

What is the current status of trial NCT01600430?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2012-06. Estimated completion is 2016-12.

What conditions does trial NCT01600430 study?

This clinical trial studies the following conditions: Vitamin D Deficiency, Bronchopulmonary Dysplasia, Preterm Infants.

What interventions are being tested in trial NCT01600430?

The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01600430?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01600430 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vitamin D Deficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01600430's enrollment target sits among peer trials

100 16th of 48 higher than 33 of 48 other Vitamin D Deficiency trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Vitamin D Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01600430, the US trial registry maintained by the National Library of Medicine. NCT01600430 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.